Loss of EHF facilitates the development of treatment-induced neuroendocrine prostate cancer

The rising of a highly aggressive subtype of castration-resistant prostate cancer (CRPC) named treatment-induced neuroendocrine prostate cancer (t-NEPC) after androgen deprivation therapy (ADT) is well known for its features of the neuroendocrine differentiation (NED) and androgen receptor (AR) inde...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Zhi, Deng, Liang, Li, Chao, He, Qiangrong, He, Yao, Hu, Xiheng, Cai, Yi, Gan, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790822/
https://www.ncbi.nlm.nih.gov/pubmed/33414441
http://dx.doi.org/10.1038/s41419-020-03326-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790822/
https://www.ncbi.nlm.nih.gov/pubmed/33414441
http://dx.doi.org/10.1038/s41419-020-03326-8

Ejemplares similares